Drug Shortage Report for APO-IRBESARTAN

Last updated on 2017-12-14 History
Report ID 339
Drug Identification Number 02386984
Brand name APO-IRBESARTAN
Common or Proper name IRBESARTAN
Company Name APOTEX INC
Active Ingredient(s) IRBESARTAN
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL & 500 BTL
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-06-17
Estimated end date 2017-12-18
Actual end date 2017-12-11
Shortage status Resolved
Updated date 2017-12-14
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2017-12-14 French Compare
v9 2017-12-14 English Compare
v8 2017-12-06 French Compare
v7 2017-12-06 English Compare
v6 2017-11-27 French Compare
v5 2017-11-27 English Compare
v4 2017-10-16 French Compare
v3 2017-10-16 English Compare
v2 2017-03-10 French Compare
v1 2017-03-10 English Compare